# Effect of Oxidative Stress Intensity on Inflammatory, Bone Turnover, and Haemostasis Biomarkers in Patients with Spinal Osteoarthritis

**Authors:** Milan Mirković, Jelena Vekić, Nataša Bogavac-Stanojević, Jelena Kotur-Stevuljević, Neda Milinković, Anđelka Milić, Sanja Mirković, Ankica Vujović, Zoran Baščarević, Biljana Božić Nedeljković

PMC · DOI: 10.3390/life16020321 · 2026-02-12

## TL;DR

This study explores how oxidative stress affects inflammation, bone turnover, and blood clotting in spinal osteoarthritis patients.

## Contribution

The study identifies PAB and D-dimer as potential biomarkers for disease severity and thrombotic risk in spinal osteoarthritis.

## Key findings

- High oxidative stress (PAB ≥ 100 U/L) correlates with elevated fibrinogen, ESR, and shortened PT/aPTT.
- Elevated D-dimer levels are strongly associated with increased ESR, IL-6, and ALP in spinal osteoarthritis patients.
- Patients with grade V disc degeneration are more likely to have elevated D-dimer levels than those with grade IV.

## Abstract

Osteoarthritis is associated with chronic inflammation, which contributes to a hypercoagulable state. Oxidative stress may further disrupt homeostatic balance, thereby promoting thrombotic events. This study evaluated the association between biomarkers of oxidative stress, inflammation, haemostasis, and bone metabolism in patients with spinal osteoarthritis. A total of 48 patients were included. The levels of inflammatory, bone turnover, haematological, and coagulation biomarkers were determined using standard laboratory methods. Redox status was assessed via prooxidant–antioxidant balance (PAB) and superoxide dismutase (SOD) activity. Patients with elevated PAB showed significantly higher erythrocyte sedimentation rate (ESR) (p = 0.005), alkaline phosphatase (ALP) (p = 0.003) and fibrinogen levels (p = 0.006) and platelet count (p = 0.040), along with lower 25-OH vitamin D levels (p = 0.045) and shortened PT (p = 0.008) and aPTT (p = 0.017). In low oxidative stress states (PAB < 100 U/L), significant correlations were observed among redox, coagulation, and bone turnover markers, whereas in high oxidative stress (PAB ≥ 100 U/L), it was characterised by predominant associations between redox and bone turnover biomarkers. Patients with grade V disc degeneration had a significantly higher probability of elevated D-dimer levels compared to those with grade IV (OR = 5.440; p = 0.009). In addition, elevated D-dimer levels were associated with increased ESR (p = 0.015), IL-6 (p = 0.016) and ALP levels (p = 0.034). The associations between biomarkers of redox status, inflammation, coagulation and bone turnover are influenced by the extent of oxidative stress. Our results suggest that PAB and D-dimer may serve as potential biomarkers for disease severity and thrombotic risk. Further studies are needed to confirm these preliminary findings.

## Full-text entities

- **Genes:** IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, SOD1 (superoxide dismutase 1) [NCBI Gene 6647] {aka ALS, ALS1, HEL-S-44, IPOA, SOD, STAHP}, BGLAP (bone gamma-carboxyglutamate protein) [NCBI Gene 632] {aka BGP, OC, OCN}, FGB (fibrinogen beta chain) [NCBI Gene 2244] {aka HEL-S-78p}, PTH (parathyroid hormone) [NCBI Gene 5741] {aka FIH1, PTH1}, ACP5 (acid phosphatase 5, tartrate resistant) [NCBI Gene 54] {aka HPAP, TRACP5a, TRACP5b, TRAP, TRAcP, TrATPase}, CALCA (calcitonin related polypeptide alpha) [NCBI Gene 796] {aka CALC1, CGRP, CGRP-I, CGRP-alpha, CGRP1, CT}, ALPP (alkaline phosphatase, placental) [NCBI Gene 250] {aka ALP, PALP, PLAP, PLAP-1}
- **Diseases:** thrombotic (MESH:D013927), vascular calcification (MESH:D061205), arthritis (MESH:D001168), lumbar disc degeneration (MESH:C535531), Spinal Osteoarthritis (MESH:D055013), coagulation (MESH:D001778), cardiovascular complications (MESH:D002318), Bone Turnover (MESH:D001847), disc (MESH:D055959), V degeneration (MESH:D009410), thromboembolic conditions (MESH:D013923), chronic (MESH:D002908), degenerative disorder (MESH:D019636), injury to (MESH:D014947), Inflammatory (MESH:D007249), Haemostasis (MESH:D020141), Lumbosacral Disc (MESH:C537221), vascular disease (MESH:D014652), obesity (MESH:D009765), bone metabolism impairment (MESH:D001851), hypercoagulation (MESH:D019851), overweight (MESH:D050177), pulmonary embolism (MESH:D011655), Osteoarthritis (MESH:D010003)
- **Chemicals:** 25-OH vitamin D (-), D (MESH:D003903), sodium citrate (MESH:D000077559), 25-hydroxy vitamin D (MESH:C104450), vitamin K (MESH:D014812), Ca (MESH:D002118), reactive oxygen species (MESH:D017382), vitamin D (MESH:D014807), EDTA (MESH:D004492)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12941861/full.md

---
Source: https://tomesphere.com/paper/PMC12941861